Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)
- Status
- COMPLETED
- Phase
- PHASE2
Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab
- Status
- UNKNOWN
- Phase
- NA
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Interactive Tailored Assessment on Patient-provider Communication
- Status
- COMPLETED
- Phase
- NA
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
- Status
- TERMINATED
- Phase
- PHASE4
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
- Status
- COMPLETED
- Phase
- PHASE3
L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Samsung Medical Center-Lymphoma Cohort Study
- Status
- COMPLETED
- Phase
- NA
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2